Acute kidney injury associated with endurance events - Is it a cause for concern? A systematic review

BMJ Open Sport and Exercise Medicine

Volumn 3, Issue 1, 2017, Pages

  Hodgson, Le ^a   Walter, E ^b   Venn, Rm ^a   Galloway, R ^c   Pitsiladis, Y ^b   Sardat, F ^d   Forni, Lg ^b,e  

^a Worthing Hospital   (United Kingdom)

^b ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SURREY   (United Kingdom)

^d ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^e Centre for Sport and Exercise Science and Medicine (SESAME)   (United Kingdom)

Author keywords

acute kidney injury; biomarkers; endurance events; marathon; non steroidal anti inflammatories

Indexed keywords

EID: 85050312216     PISSN: 20557647     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmjsem-2015-000093     Document Type: Article

References (121)

1. RunningUSA. Annual Marathon Report, Running USA. 2014.
2. Zaryski C, Smith DJ. Training principles and issues for ultra-endurance athletes. Curr Sports Med Rep 2005;4:165-70.
3. Chakravarty EF, Hubert HB, Lingala VB, et al. Reduced disability and mortality among aging runners: a 21-year longitudinal study. Arch Intern Med 2008;168:1638-46.
4. Sarna S, Sahi T, Koskenvuo M, et al. Increased life expectancy of world class Male athletes. Med Sci Sports Exerc 1993;25:237-44.
5. Schnohr P, Marott JL, Lange P, et al. Longevity in Male and female joggers: the Copenhagen City Heart Study. Am J Epidemiol 2013;177:683-9.
6. Pugh A, Bourke JP, Kunadian V. Sudden cardiac death among competitive adult athletes: a review. Postgrad Med J 2012;88:382-90.
7. Sharma S, Whyte G, McKenna WJ. Sudden death from cardiovascular disease in young athletes: fact or fiction? Br J Sports Med 1997;31:269-76.
8. Kim JH, Malhotra R, Chiampas G, et al; Race Associated Cardiac Arrest Event Registry (RACER) Study Group. Cardiac arrest during long-distance running races. N Engl J Med 2012;366:130-40.
9. Corrado D, Basso C, Thiene G. Sudden cardiac death in athletes: what is the role of screening? Curr Opin Cardiol 2012;27:41-8.
10. Benito B, Gay-Jordi G, Serrano-Mollar A, et al. Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training. Circulation 2011;123:13-22.
11. Scharhag J, George K, Shave R, et al. Exercise-associated increases in cardiac biomarkers. Med Sci Sports Exerc 2008;40:1408-15.
12. Middleton N, George K, Whyte G, et al. Cardiac troponin T release is stimulated by endurance exercise in healthy humans. J Am Coll Cardiol 2008;52:1813-4.
13. Rifai N, Douglas PS, O'Toole M, et al. Cardiac troponin T and I, echocardiographic [correction of electrocardiographic] wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon. Am J Cardiol 1999;83:1085-9.
14. Neilan TG, Januzzi JL, Lee-Lewandrowski E, et al. Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon. Circulation 2006;114:2325-33.
15. Shave R, Baggish A, George K, et al. Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications. J Am Coll Cardiol 2010;56:169-76.
16. Neumayr G, Gaenzer H, Pfister R, et al. Plasma levels of cardiac troponin I after prolonged strenuous endurance exercise. Am J Cardiol 2001;87:369-71.
17. Scherr J, Braun S, Schuster T, et al. 72-h kinetics of high-sensitive troponin T and inflammatory markers after marathon. Med Sci Sports Exerc 2011;43:1819-27.
18. Neilan TG, Yoerger DM, Douglas PS, et al. Persistent and reversible cardiac dysfunction among amateur marathon runners. Eur Heart J 2006;27:1079-84.
19. Trivax JE, Franklin BA, Goldstein JA, et al. Acute cardiac effects of marathon running. J Appl Physiol 2010;108:1148-53.
20. Lee DC, Pate RR, Lavie CJ, et al. Leisure-time running reduces all-cause and cardiovascular mortality risk. J Am Coll Cardiol 2014;64:472-81.
21. Schnohr P, O'Keefe JH, Marott JL, et al. Dose of jogging and long-term mortality: the Copenhagen City Heart Study. J Am Coll Cardiol 2015;65:411-9.
22. Mons U, Hahmann H, Brenner H. A reverse J-shaped association of leisure time physical activity with prognosis in patients with stable coronary heart disease: evidence from a large cohort with repeated measurements. Heart 2014;100:1043-9.
23. Bellomo R, Ronco C, Kellum JA, et al; Acute Dialysis Quality Initiative workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-12.
24. KDIGO clinical practice guideline for acute kidney injury. Kidney Int 2012;2(Suppl 1):1-136.
25. Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16:3365-70.
26. Lassnigg A, Schmid ER, Hiesmayr M, et al. Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure? Crit Care Med 2008;36:1129-37.
27. Newsome BB, Warnock DG, McClellan WM, et al. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med 2008;168:609-16.
28. Bywaters EG, Beall D. Crush Injuries with Impairment of renal Function. Br Med J 1941;1:427-32.
29. Ra B. Urinary findings before and after a marathon race. N Engl J Med 1941;225:801-2.
30. Dancaster CP, Duckworth WC, Roper CJ. Nephropathy in marathon runners. S Afr Med J 1969;43:758-60.
31. Seedat YK, Aboo N, Naicker S, et al. Acute renal failure in the "Comrades Marathon" runners. Ren Fail 1989;11:209-12.
32. Schiff HB, MacSearraigh ET, Kallmeyer JC. Myoglobinuria, rhabdomyolysis and marathon running. Q J Med 1978;47:463-72.
33. Vitting KE, Nichols NJ, Seligson GR. Naproxen and acute renal failure in a runner. Ann Intern Med 1986;105:144.
34. Whitworth JA, Wolfman MJ. Fatal heat stroke in a long distance runner. Br Med J 1983;287:948.
35. Irving RA, Noakes TD, Irving GA, et al. The immediate and delayed effects of marathon running on renal function. J Urol 1986;136:1176-80.
36. Antman EM, Lau J, Kupelnick B, et al. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. treatments for myocardial infarction. JAMA 1992;268:240-8.
37. Oxman AD, Guyatt GH. The science of reviewing research. Ann N Y Acad Sci 1993;703:125-33.
38. Wells G, Shea B, Peterson J, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.
39. Patra J, Bhatia M, Suraweera W, et al. Exposure to second-hand smoke and the risk of tuberculosis in children and adults: a systematic review and meta-analysis of 18 observational studies. PLoS Med 2015;12:e1001835.
40. Pollard TD, Weiss IW. Acute tubular necrosis in a patient with march hemoglobinuria. N Engl J Med 1970;283:803-4.
41. Bar-Sela S, Tur-Kaspa R, Eliakim M. Rhabdomyolysis and acute renal failure in a marathon runner in israel. Isr J Med Sci 1979;15:464-6.
42. Goldsmith HJ. Acute renal failure after a marathon run. Lancet 1984;1:278-9.
43. Le Meur Y, Paraf F, Szelag JC, et al. Acute renal failure in a marathon runner: role of glomerular bleeding in tubular injury. Am J Med 1998;105:251-2.
44. Bruso JR, Hoffman MD, Rogers IR, et al. Rhabdomyolysis and hyponatremia: a cluster of five cases at the 161-km 2009 western States endurance Run. Wilderness Environ Med 2010;21:303-8.
45. MacSearraigh ET, Kallmeyer JC, Schiff HB. Acute renal failure in marathon runners. Nephron 1979;24:236-40.
46. van Zyl-Smit R, Mills P, Vogelpoel L. Unrecognized acute renal failure following the comrades marathon. S Afr Med J 2000;90:39-40.
47. Boulter J, Noakes TD, Hew-Butler T. Acute renal failure in four comrades marathon runners ingesting the same electrolyte supplement: coincidence or causation? S Afr Med J 2011;101:876-8.
48. Riley WJ, Pyke FS, Roberts AD, et al. The effect of long-distance running on some biochemical variables. Clin Chim Acta 1975;65:83-9.
49. Neviackas JA, Bauer JH. Renal function abnormalities induced by marathon running. South Med J 1981;74:1457-60.
50. Kraemer RR, Brown BS. Alterations in plasma-volume-corrected blood components of marathon runners and concomitant relationship to performance. Eur J Appl Physiol Occup Physiol 1986;55:579-84.
51. Holtzhausen LM, Noakes TD, Kroning B, et al. Clinical and biochemical characteristics of collapsed ultra-marathon runners. Med Sci Sports Exerc 1994;26:1095-101.
52. Kratz A, Lewandrowski KB, Siegel AJ, et al. Effect of marathon running on hematologic and biochemical laboratory parameters, including cardiac markers. Am J Clin Pathol 2002;118:856-63.
53. Reid SA, Speedy DB, Thompson JM, et al. Study of hematological and biochemical parameters in runners completing a standard marathon. Clin J Sport Med 2004;14:344-53.
54. Mingels A, Jacobs L, Kleijnen V, et al. Cystatin C a marker for renal function after exercise. Int J Sports Med 2009;30:668-71.
55. McCullough PA, Chinnaiyan KM, Gallagher MJ, et al. Changes in renal markers and acute kidney injury after marathon running. Nephrology 2011;16:194-9.
56. Mydlík M, Derzsiova K, Bohus B. Renal function abnormalities after marathon run and 16-kilometre long-distance run. Przegl Lek 2012;69:1-4.
57. Borkowski J, Sobiech KA. Protein: creatinine and trypsin inhibitor: creatinine ratios in the urine of marathon runners. Eur J Appl Physiol Occup Physiol 1990;61:124-7.
58. Nelson PB, Ellis D, Fu F, et al. Fluid and electrolyte balance during a cool weather marathon. Am J Sports Med 1989;17:770-2.
59. Hewing B, Schattke S, Spethmann S, et al. Cardiac and renal function in a large cohort of amateur marathon runners. Cardiovasc Ultrasound 2015;13:13:13.
60. Irving RA, Noakes TD, Burger SC, et al. Plasma volume and renal function during and after ultramarathon running. Med Sci Sports Exerc 1990;22:581-7.
61. Irving RA, Noakes TD, Buck R, et al. Evaluation of renal function and fluid homeostasis during recovery from exercise-induced hyponatremia. J Appl Physiol 1991;70:342-8.
62. Lippi G, Sanchis-Gomar F, Salvagno GL, et al. Variation of serum and urinary neutrophil gelatinase associated lipocalin (NGAL) after strenuous physical exercise. Clin Chem Lab Med 2012;50:1585-9.
63. Hoffman MD, Stuempfle KJ, Fogard K, et al. Urine dipstick analysis for identification of runners susceptible to acute kidney injury following an ultramarathon. J Sports Sci 2013;31:20-31.
64. Noakes TD, Carter JW. Biochemical parameters in athletes before and after having run 160 kilometres. S Afr Med J 1976;50:1562-6.
65. Irving RA, Noakes TD, Raine RI, et al. Transient oliguria with renal tubular dysfunction after a 90 km running race. Med Sci Sports Exerc 1990;22:756-61.
66. Lipman GS, Krabak BJ, Waite BL, et al. A prospective cohort study of acute kidney injury in multi-stage ultramarathon runners: the Biochemistry in endurance Runner Study (BIERS). Res Sports Med 2014;22:185-92.
67. Hou SK, Chiu YH, Tsai YF, et al. Clinical Impact of Speed Variability to identify Ultramarathon Runners at Risk for acute Kidney Injury. PLoS One 2015;10:e0133146.
68. Christensen DL, Espino D, Infante-Ramírez R, et al. Normalization of elevated cardiac, kidney, and hemolysis plasma markers within 48 h in Mexican Tarahumara runners following a 78 km race at moderate altitude. Am J Hum Biol 2014;26:836-43.
69. Dumke CL, Nieman DC, Oley K, et al. Ibuprofen does not affect serum electrolyte concentrations after an ultradistance run. Br J Sports Med 2007;41:492-6.
70. Lippi G, Schena F, Salvagno GL, et al. Acute variation of estimated glomerular filtration rate following a half-marathon run. Int J Sports Med 2008;29:948-51.
71. Mohseni M, Silvers S, McNeil R, et al. Prevalence of hyponatremia, renal dysfunction, and other electrolyte abnormalities among runners before and after completing a marathon or half marathon. Sports Health 2011;3:145-51.
72. Wharam PC, Speedy DB, Noakes TD, et al. NSAID use increases the risk of developing hyponatremia during an ironman triathlon. Med Sci Sports Exerc 2006;38:618-22.
73. Irving RA, Noakes TD, van Zyl Smit R. Metabolic and renal changes in two athletes during a world 24 hour relay record performance. Br J Sports Med 1989;23:227-32.
74. Page AJ, Reid SA, Speedy DB, et al. Exercise-associated hyponatremia, renal function, and nonsteroidal antiinflammatory drug use in an ultraendurance mountain run. Clin J Sport Med 2007;17:43-8.
75. Neumayr G, Pfister R, Hoertnagl H, et al. The effect of marathon cycling on renal function. Int J Sports Med 2003;24:131-7.
76. Neumayr G, Pfister R, Hoertnagl H, et al. Renal function and plasma volume following ultramarathon cycling. Int J Sports Med 2005;26:2-8.
77. Reid SA, King MJ. Serum biochemistry and morbidity among runners presenting for medical care after an Australian mountain ultramarathon. Clin J Sport Med 2007;17:307-10.
78. Schutz UH, Schmidt-Trucksass A, Knechtle B, et al; The TransEurope FootRace Project. longitudinal data acquisition in a cluster randomized mobile MRI observational cohort study on 44 endurance runners at a 64-stage 4486 km transcontinental ultramarathon. BMC Med 2012;10:78.
79. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002;40:221-6.
80. Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013;17:R25.
81. Bihorac A, Chawla LS, Shaw AD, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 2014;189:932-9.
82. Koyner JL, Shaw AD, Chawla LS, et al; Sapphire Investigators. Tissue Inhibitor Metalloproteinase-2 (TIMP-2)-IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI. J Am Soc Nephrol 2015;26:1747-54.
83. Castenfors J, Mossfeldt F, Piscator M. Effect of prolonged heavy exercise on renal function and urinary protein excretion. Acta Physiol Scand 1967;70:194-206.
84. Poortmans JR. Exercise and renal function. Sports Med 1984;1:125-53.
85. Castenfors J. Renal function during prolonged exercise. Ann N Y Acad Sci 1977;301:151-9.
86. Grimby G. Renal clearances during prolonged supine exercise at different loads. Journal of Applied Physiology 1965;20:1294-8.
87. Kohler H. Fluid metabolism in exercise. Kidney Int Suppl 1987;21:S93-6.
88. Poortmans JR, Vanderstraeten J. Kidney function during exercise in healthy and diseased humans. an update. Sports Med 1994;18:419-37.
89. Rocker L, Kirsch KA, Heyduck B, et al. Influence of prolonged physical exercise on plasma volume, plasma proteins, electrolytes, and fluid-regulating hormones. Int J Sports Med 1989;10:270-4.
90. Kosunen KJ, Pakarinen AJ. Plasma renin, angiotensin II, and plasma and urinary aldosterone in running exercise. J Appl Physiol 1976;41:26-9.
91. McAllister RM. Adaptations in control of blood flow with training: splanchnic and renal blood flows. Med Sci Sports Exerc 1998;30:375-81.
92. Armstrong RB. Muscle damage and endurance events. Sports Med 1986;3:370-81.
93. Newham DJ, Jones DA, Edwards RH. Large delayed plasma creatine kinase changes after stepping exercise. Muscle Nerve 1983;6:380-5.
94. Noakes TD. Effect of exercise on serum enzyme activities in humans. Sports Med 1987;4:245-67.
95. Brody SL, Wrenn KD, Wilber MM, et al. Predicting the severity of cocaine-associated rhabdomyolysis. Ann Emerg Med 1990;19:1137-43.
96. Ward MM. Factors predictive of acute renal failure in rhabdomyolysis. Arch Intern Med 1988;148:1553-7.
97. Skenderi KP, Kavouras SA, Anastasiou CA, et al. Exertional Rhabdomyolysis during a 246-km continuous running race. Med Sci Sports Exerc 2006;38:1054-7.
98. Demos MA, Gitin EL, Kagen LJ. Exercise myoglobinemia and acute exertional rhabdomyolysis. Arch Intern Med 1974;134:669-73.
99. Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med 2009;361:62-72.
100. Murray MD, Brater DC. Renal toxicity of the nonsteroidal anti-inflammatory drugs. Annu Rev Pharmacol Toxicol 1993;33:435-65.
101. Kramer HJ, Stinnesbeck B, Klautke G, et al. Interaction of renal prostaglandins with the renin-angiotensin and renal adrenergic nervous systems in healthy subjects during dietary changes in sodium intake. Clin Sci 1985;68:387-93.
102. Stokes JB. Effect of prostaglandin E2 on chloride transport across the rabbit thick ascending limb of Henle. selective inhibitions of the medullary portion. J Clin Invest 1979;64:495-502.
103. Anderson RJ, Berl T, McDonald KD, et al. Evidence for an in vivo antagonism between vasopressin and prostaglandin in the mammalian kidney. J Clin Invest 1975;56:420-6.
104. Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999;106:S13-24.
105. Sedor JR, Davidson EW, Dunn MJ. Effects of nonsteroidal anti-inflammatory drugs in healthy subjects. Am J Med 1986;81:58-70.
106. Walker RJ, Fawcett JP, Flannery EM, et al. Indomethacin potentiates exercise-induced reduction in renal hemodynamics in athletes. Med Sci Sports Exerc 1994;26:1302-6.
107. Olsen NV, Jensen NG, Hansen JM, et al. Non-steroidal anti-inflammatory drugs and renal response to exercise: a comparison of Indomethacin and nabumetone. Clin Sci 1999;97:457-65.
108. Donnelly AE, Maughan RJ, Whiting PH. Effects of ibuprofen on exercise-induced muscle soreness and indices of muscle damage. Br J Sports Med 1990;24:191-5.
109. Bourgeois J, MacDougall D, MacDonald J, et al. Naproxen does not alter indices of muscle damage in resistance-exercise trained men. Med Sci Sports Exerc 1999;31:4-9.
110. Donnelly AE, McCormick K, Maughan RJ, et al. Effects of a non-steroidal anti-inflammatory drug on delayed onset muscle soreness and indices of damage. Br J Sports Med 1988;22:35-8.
111. Carter R. 3rd, Cheuvront SN, Williams JO, et al. Epidemiology of hospitalizations and deaths from heat illness in soldiers. Med Sci Sports Exerc 2005;37:1338-44.
112. Pattison ME, Logan JL, Lee SM, et al. Exertional heat stroke and acute renal failure in a young woman. Am J Kidney Dis 1988;11:184-7.
113. Holman ND, Schneider AJ. Multi-organ damage in exertional heat stroke. Neth J Med 1989;35:38-43.
114. Roberts WO. Exertional heat stroke during a cool weather marathon: a case study. Med Sci Sports Exerc 2006;38:1197-203.
115. Walter E, Venn R, Stevenson T. Exertional Heat Stroke-The Athlete's Nemesis. Journal of the Intensive Care Society 2012;13:304-8.
116. Bouchama A, Knochel JP. Heat stroke. N Engl J Med 2002;346:1978-88.
117. Racinais S, Alonso JM, Coutts AJ, et al. Consensus recommendations on training and competing in the heat. Sports Med 2015;45:925-38.
118. Ishikawa I. Acute renal failure with severe loin pain and patchy renal ischemia after anaerobic exercise in patients with or without renal hypouricemia. Nephron 2002;91:559-70.
119. Izumi M, Yokoyama K, Yamauchi A, et al. A young man with acute renal failure and severe loin pain. Nephron 1997;76:215-7.
120. Han JS, Kim YG, Kim S, et al. Bone scintigraphy in acute renal failure with severe loin pain and patchy renal vasoconstriction. Nephron 1991;59:254-60.
121. Mehta RL, Kellum JA, Shah SV, et al; Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31.